Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models.
Int J Mol Sci. 2022 May 18;23(10):5634. doi: 10.3390/ijms23105634.
Int J Mol Sci. 2022.
PMID: 35628443
Free PMC article.
Review.
Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats.
Aragón-Herrera A, Feijóo-Bandín S, Otero Santiago M, Barral L, Campos-Toimil M, Gil-Longo J, Costa Pereira TM, García-Caballero T, Rodríguez-Segade S, Rodríguez J, Tarazón E, Roselló-Lletí E, Portolés M, Gualillo O, González-Juanatey JR, Lago F.
Aragón-Herrera A, et al. Among authors: otero santiago m.
Biochem Pharmacol. 2019 Dec;170:113677. doi: 10.1016/j.bcp.2019.113677. Epub 2019 Oct 21.
Biochem Pharmacol. 2019.
PMID: 31647926
Item in Clipboard
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile.
Aragón-Herrera A, Otero-Santiago M, Anido-Varela L, Moraña-Fernández S, Campos-Toimil M, García-Caballero T, Barral L, Tarazón E, Roselló-Lletí E, Portolés M, Gualillo O, Moscoso I, Lage R, González-Juanatey JR, Feijóo-Bandín S, Lago F.
Aragón-Herrera A, et al. Among authors: otero santiago m.
Front Pharmacol. 2022 Feb 2;13:827033. doi: 10.3389/fphar.2022.827033. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35185578
Free PMC article.
Item in Clipboard
Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy.
Ferreiro-Iglesias R, Barreiro-de Acosta M, Otero Santiago M, Lorenzo Gonzalez A, Alonso de la Peña C, Benitez Estevez AJ, Dominguez-Muñoz JE.
Ferreiro-Iglesias R, et al. Among authors: otero santiago m.
J Clin Gastroenterol. 2016 Feb;50(2):147-51. doi: 10.1097/MCG.0000000000000312.
J Clin Gastroenterol. 2016.
PMID: 25811118
Item in Clipboard
Knowledge, Perceptions, and Perspectives of Medical Students Regarding the Use of Antibiotics and Antibiotic Resistance: A Qualitative Research in Galicia, Spain.
Vázquez-Lago JM, Montes-Villalba RA, Vázquez-Cancela O, Otero-Santiago M, López-Durán A, Figueiras A.
Vázquez-Lago JM, et al. Among authors: otero santiago m.
Antibiotics (Basel). 2023 Mar 11;12(3):558. doi: 10.3390/antibiotics12030558.
Antibiotics (Basel). 2023.
PMID: 36978424
Free PMC article.
Item in Clipboard
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats.
Aragón-Herrera A, Moraña-Fernández S, Otero-Santiago M, Anido-Varela L, Campos-Toimil M, García-Seara J, Román A, Seijas J, García-Caballero L, Rodríguez J, Tarazón E, Roselló-Lletí E, Portolés M, Lage R, Gualillo O, González-Juanatey JR, Feijóo-Bandín S, Lago F.
Aragón-Herrera A, et al. Among authors: otero santiago m.
Biomed Pharmacother. 2023 May;161:114535. doi: 10.1016/j.biopha.2023.114535. Epub 2023 Mar 15.
Biomed Pharmacother. 2023.
PMID: 36931025
Free article.
Item in Clipboard
Epidemiology of tuberculosis in Galicia, Spain, 16 years after the launch of the Galician tuberculosis programme.
Cruz-Ferro E, Ursúa-Díaz MI, Taboada-Rodríguez JA, Hervada-Vidal X, Anibarro L, Túñez V; Galician Tuberculosis Prevention and Control Programme Working Group.
Cruz-Ferro E, et al.
Int J Tuberc Lung Dis. 2014 Feb;18(2):134-40. doi: 10.5588/ijtld.13.0419.
Int J Tuberc Lung Dis. 2014.
PMID: 24429303
Item in Clipboard
Cite
Cite